Deutsche Bank’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-609,809
Closed -$2.07M 5099
2018
Q3
$2.07M Buy
609,809
+324,464
+114% +$1.1M ﹤0.01% 2815
2018
Q2
$1.07M Sell
285,345
-19,377
-6% -$72.9K ﹤0.01% 3344
2018
Q1
$1.25M Buy
304,722
+98,789
+48% +$404K ﹤0.01% 3149
2017
Q4
$956K Buy
205,933
+104,585
+103% +$486K ﹤0.01% 3171
2017
Q3
$718K Buy
101,348
+2,972
+3% +$21.1K ﹤0.01% 3163
2017
Q2
$710K Buy
98,376
+75,032
+321% +$542K ﹤0.01% 3184
2017
Q1
$142K Sell
23,344
-37,161
-61% -$226K ﹤0.01% 3591
2016
Q4
$353K Sell
60,505
-104,357
-63% -$609K ﹤0.01% 3279
2016
Q3
$873K Buy
164,862
+10,167
+7% +$53.8K ﹤0.01% 2849
2016
Q2
$1.02M Buy
154,695
+133,316
+624% +$881K ﹤0.01% 2836
2016
Q1
$98K Sell
21,379
-26,594
-55% -$122K ﹤0.01% 3853
2015
Q4
$240K Sell
47,973
-294,829
-86% -$1.47M ﹤0.01% 3505
2015
Q3
$1.21M Buy
342,802
+169,299
+98% +$595K ﹤0.01% 2786
2015
Q2
$1.73M Buy
173,503
+105,068
+154% +$1.05M ﹤0.01% 2554
2015
Q1
$868K Sell
68,435
-152,952
-69% -$1.94M ﹤0.01% 2905
2014
Q4
$3.13M Sell
221,387
-22,839
-9% -$323K ﹤0.01% 2305
2014
Q3
$3.35M Buy
244,226
+184,631
+310% +$2.54M ﹤0.01% 2098
2014
Q2
$914K Sell
59,595
-14,270
-19% -$219K ﹤0.01% 2954
2014
Q1
$1.26M Sell
73,865
-13,472
-15% -$229K ﹤0.01% 2708
2013
Q4
$1.13M Sell
87,337
-822,858
-90% -$10.6M ﹤0.01% 2590
2013
Q3
$9.18M Buy
910,195
+820,648
+916% +$8.28M 0.01% 1385
2013
Q2
$667K Buy
+89,547
New +$667K ﹤0.01% 2979